BOTOX Could Solve Pediatric Migraines
The muscle injection therapy is currently only approved for adult migraine patients. One researcher wants to change that.
Read More
Revised Declaration of Geneva Could Replace Hippocratic Oath
The most recent WMA revised declaration brings attention to possible physician burnout.
Circumcision Combats HIV, STI Rates
A review found that the voluntary procedure could greatly benefit areas affected by sexually transmitted disease-related deaths.
Air Pollution Deaths Reach New Global Highs
Ambient air pollution-related deaths now total more annually than AIDS, tuberculosis, and malaria combined.
FDA Roundup of the Week: October 20
Catch up on all the past week's action in US Food and Drug Administration rulings and decisions.
REVOLVE Trial for Crohn's Disease Canceled
The FDA Data Monitoring Committee recommended Celgene discontinue the mongersen trials.
Legislators Bridge ACA Cut, Discuss Drug Costs
On the same day, US senators extended Obamacare subsidies and took on overall drug costs.
Ingrezza Continues to Expand in TD Market
The valbenazine therapy was indicated for 80 mg capsule therapy by the FDA.
Dupilumab Returns Strong Eosinophilic Esophagitis Response
The monoclonal antibody reported positive phase 2 trial results for eosinophilic esophagitis.
Infections, Illnesses Loom in Puerto Rico Aftermath
Weeks after Hurricanes Maria and Irma, the US territory races bacteria to restoring public health infrastructure.
FDA Roundup of the Week: October 13
FDA Committee Backs Gene Therapy Candidate
An advisory committee gave unanimous support to Luxturna, 3 months prior to its BLA ruling.
FDA Approves First 7 Tesla MRI Device
The approval of Magnetom Terra more than doubles the maximum MRI strength in the field.
FDA Requests More Pain Medication Data
AcelRx Pharmaceutical's New Drug Application for DSUVIA was rebuffed, pending more safety and use data.
FDA Approves LivaNova Epilepsy Device
SenTiva is capable of detecting and responding to seizures in patients — before they even begin.
Eravacycline Improves Regimen for Oral, IV Treatment of cUTI
Treated in hospital settings, cUTI has been traditionally treated with quinolones due to a patient’s ability to transfer from IV to oral form when they’re discharged.
California Passes Drug Price Transparency Law
Drug manufactures will have to explain any raise of at least 16% over a 2-year span.
FDA Approves Implantable Sleep Apnea Device
The Remedē System stimulates the phrenic nerve during sleep to retain normal breathing in patients.
How HCV Drug Makers Hit a Wall
National reports show less treated patients and less spending in a field that major developers are now leaving.
FDA Approves Zika Virus Blood Test
This was the first FDA approval of such a detection test for screening national blood supplies.
Gilead Gives UN Organization Licensing Rights to HIV Drug
As a result the Medicines Patent Pool will have sub-license rights to generic drugmakers in India, China, and South Africa for the integrase stand inhibitor drug.
NIH Institute Grants $122 Million to Research Minority Institutes
NIMHD, a part of the National Institutes of Health, supports scientists at institutions historically committed to training populations underrepresented in science.
The "Universal Flu Vaccine" Undergoes 2,000-patient Trial
Developed by Oxford University researchers, the vaccine could possibly be administered in 5-year intervals.
Copaxone Generic Approved for Multiple Sclerosis
At the time of the approval, Mylan is awaiting decision on another 225 ANDAs submitted to the FDA.
FDA Approves BOTOX Cosmetic for Third Indication
After previous indications in 2002 and 2013, the drug received its third indication for temporary improvement in the appearance of moderate to severe forehead lines associated with frontalis muscle activity
Merck Ends 2 HCV Drug Trials Due to "Evolving Marketplace"
The pharmaceutical company follows Johnson & Johnson's pursuit of fields outside of hepatitis C.
Breakthrough: CTE Biomarker Could Lead to Treatments
There's a growing chance that living patients can be tested for the neurodegenerative disease most linked to tackle football.
MD Magazine's Top 10 Stories of September
Catch up on our biggest headlines you missed before the end of the month!
A Damaged Car: Experts Discuss the Next Healthcare Bill Moves
Organized by the Harvard T.H. Chan School of Public Health, a panel of experts projected a foggy future for the ACA.
AbbVie, Amgen Settle on Humira Biosimilar Litigation
Amgen biosimilar Amgevita may be on US markets in about 7 years.